| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006486551 |
| P356 | DOI | 10.1038/MODPATHOL.2010.135 |
| P698 | PubMed publication ID | 20711171 |
| P5875 | ResearchGate publication ID | 45651078 |
| P2093 | author name string | Vani Santosh | |
| Kumaravel Somasundaram | |||
| Soumya A M Rao | |||
| P2860 | cites work | MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. | Q38358928 |
| Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal | Q39916475 | ||
| MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a | Q39936936 | ||
| Regulation of the p53 homolog p73 by adenoviral oncogene E1A. | Q40663618 | ||
| Cancer statistics, 1999. | Q40817780 | ||
| Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality | Q48132856 | ||
| Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? | Q51912002 | ||
| miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 | ||
| Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development | Q24317761 | ||
| MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 | ||
| Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme | Q24555728 | ||
| Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
| microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 | ||
| Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling | Q28297583 | ||
| Diagnosis of multiple cancer types by shrunken centroids of gene expression | Q29615528 | ||
| Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
| Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma | Q30014823 | ||
| MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes | Q30434616 | ||
| Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials | Q30686073 | ||
| Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery | Q33483488 | ||
| Anaplastic astrocytoma in adults. | Q34579207 | ||
| A comparison of background correction methods for two-colour microarrays | Q34667581 | ||
| MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells | Q34842477 | ||
| Identification and functional characterization of microRNAs involved in the malignant progression of gliomas | Q35004717 | ||
| Genetic pathways to primary and secondary glioblastoma | Q35757144 | ||
| Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents | Q36395924 | ||
| MicroRNA trafficking and human cancer | Q36499883 | ||
| Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. | Q36748177 | ||
| Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. | Q38290930 | ||
| Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma | Q38322081 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1404-1417 | |
| P577 | publication date | 2010-08-13 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma | |
| P478 | volume | 23 |
| Q37514165 | A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma |
| Q42366643 | A cerebrospinal fluid microRNA signature as biomarker for glioblastoma |
| Q43894472 | A microRNA expression signature predicts meningioma recurrence |
| Q37641229 | A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool |
| Q45256953 | A specific miRNA signature in the peripheral blood of glioblastoma patients |
| Q24633772 | A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion |
| Q33869822 | A ten-microRNA expression signature predicts survival in glioblastoma |
| Q38935921 | A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes |
| Q89687445 | Aberrant expression of long non-coding RNAs (lncRNAs) is involved in brain glioma development |
| Q43217216 | Aberrant miRNA expression in brain tumors: a subject attracting an increasing amount of attention |
| Q34991261 | Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis |
| Q35871493 | Apoptosis and the target genes of microRNA-21. |
| Q94525649 | Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma |
| Q45673083 | Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor-suppressive miR-124. |
| Q26830329 | Circulating glioma biomarkers |
| Q41872498 | Clinical implications of microRNAs in human glioblastoma |
| Q35830062 | Compound 331 selectively induces glioma cell death by upregulating miR-494 and downregulating CDC20. |
| Q41136585 | Comprehensive analysis of microRNA expression profile in malignant glioma tissues |
| Q37528839 | Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression. |
| Q55461301 | Decreased expression of microRNA-206 correlates with poor clinical outcome in patients with malignant astrocytomas. |
| Q33979622 | Disease biology in the coming decade(s) |
| Q43517810 | Down-regulation of miR-106b suppresses the growth of human glioma cells |
| Q42119044 | Downregulation of miR-544 in tissue, but not in serum, is a novel biomarker of malignant transformation in glioma |
| Q45613688 | Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors |
| Q40606959 | Expression Profile of MiR-128 in the Astrocytoma Patients and Cell Lines |
| Q55216211 | Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma. |
| Q41135067 | Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. |
| Q91584608 | Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis |
| Q39069297 | Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival |
| Q48151439 | Expression of microRNAs in tumors of the central nervous system in pediatric patients in México |
| Q55317834 | Expression of p53 & epidermal growth factor receptor in glioblastoma. |
| Q42157978 | Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions |
| Q34257360 | Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. |
| Q26765758 | Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets |
| Q37567317 | Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma |
| Q33688677 | Identification of microRNAs associated with glioma diagnosis and prognosis |
| Q34279430 | Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas |
| Q46969516 | Identification of the transcription factor HOXB4 as a novel target of miR-23a. |
| Q38435063 | Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor. |
| Q44821104 | Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma |
| Q42367903 | Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219. |
| Q38439094 | Long noncoding RNA profiles reveal three molecular subtypes in glioma |
| Q46677764 | MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. |
| Q92540204 | MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients |
| Q38793204 | MiR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1. |
| Q36713464 | MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity |
| Q40581942 | MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors |
| Q39519803 | MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation |
| Q44522644 | MiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth |
| Q41208796 | MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. |
| Q38590626 | MicroRNA as potential biomarkers in Glioblastoma |
| Q38108768 | MicroRNA biomarkers in glioblastoma |
| Q34409620 | MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. |
| Q37619633 | MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b |
| Q35551867 | MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma. |
| Q38824154 | MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. |
| Q35192143 | MicroRNA-146a inhibits glioma development by targeting Notch1 |
| Q38736662 | MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme |
| Q35077874 | MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. |
| Q40230602 | MicroRNA-15b target Sall4 and diminish in vitro UCB-derived HSCs expansion. |
| Q45328105 | MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma |
| Q38972375 | MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion |
| Q39342199 | MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. |
| Q47094148 | MicroRNA-219 exerts a tumor suppressive role in glioma via targeting Sal-like protein 4. |
| Q34699904 | MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation |
| Q38863240 | MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1 in glioblastoma |
| Q34991208 | MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value |
| Q59795393 | MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma |
| Q46190130 | MicroRNA-target cross-talks: Key players in glioblastoma multiforme |
| Q37897499 | MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme |
| Q42242451 | MicroRNAs in Human Malignant Gliomas |
| Q37899077 | MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective? |
| Q26865287 | MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells |
| Q37001046 | Network analysis of microRNAs, transcription factors, target genes and host genes in human anaplastic astrocytoma |
| Q56689570 | New molecular tests for brain tumor |
| Q64251635 | N⁶-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling |
| Q41391958 | Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. |
| Q37426405 | PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA. |
| Q64116760 | Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis |
| Q45871459 | RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials |
| Q92592923 | RNA processing genes characterize RNA splicing and further stratify lower-grade glioma |
| Q21135142 | Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme |
| Q54213859 | Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children. |
| Q38108186 | Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach |
| Q44744230 | Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. |
| Q38027227 | Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy |
| Q39048843 | Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. |
| Q38984993 | The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells |
| Q30428370 | The role of microRNAs in glioma initiation and progression |
| Q36300857 | cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a |
| Q36545707 | miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal |
| Q39646428 | miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β |
| Q35167790 | miR-218 inhibits the migration and invasion of glioma U87 cells through the Slit2-Robo1 pathway |
| Q35759046 | miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway |
| Q33276346 | miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence |
| Q30419258 | miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma |
| Q38962553 | miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. |
| Q39254996 | miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications |
| Q36312098 | miRNA-218 contributes to the regulation of D-glucuronyl C5-epimerase expression in normal and tumor breast tissues. |
| Q90706419 | microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance |
Search more.